IS5731A - 4, 5, 6 og 7-indól og indólín afleiður, framleiðsla þeirra og notkun - Google Patents

4, 5, 6 og 7-indól og indólín afleiður, framleiðsla þeirra og notkun

Info

Publication number
IS5731A
IS5731A IS5731A IS5731A IS5731A IS 5731 A IS5731 A IS 5731A IS 5731 A IS5731 A IS 5731A IS 5731 A IS5731 A IS 5731A IS 5731 A IS5731 A IS 5731A
Authority
IS
Iceland
Prior art keywords
indole
production
indoline derivatives
indoline
derivatives
Prior art date
Application number
IS5731A
Other languages
English (en)
Inventor
Knud Moltzen Ejner
Mikkelsen Ivan
Krog - Jensen Christian
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/DK1999/000326 external-priority patent/WO1999067237A1/en
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Publication of IS5731A publication Critical patent/IS5731A/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
IS5731A 1998-06-19 2000-11-24 4, 5, 6 og 7-indól og indólín afleiður, framleiðsla þeirra og notkun IS5731A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK82098 1998-06-19
PCT/DK1999/000326 WO1999067237A1 (en) 1998-06-19 1999-06-14 4,5,6 and 7-indole and indoline derivatives, their preparation and use

Publications (1)

Publication Number Publication Date
IS5731A true IS5731A (is) 2000-11-24

Family

ID=8097932

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5731A IS5731A (is) 1998-06-19 2000-11-24 4, 5, 6 og 7-indól og indólín afleiður, framleiðsla þeirra og notkun

Country Status (16)

Country Link
US (2) US6391882B1 (is)
KR (1) KR20010071513A (is)
CN (1) CN1336925A (is)
AR (1) AR018899A1 (is)
BR (1) BR9911843A (is)
CZ (1) CZ20004780A3 (is)
EA (1) EA004248B1 (is)
HK (1) HK1044339A1 (is)
ID (1) ID27976A (is)
IL (1) IL139962A0 (is)
IS (1) IS5731A (is)
PL (1) PL344978A1 (is)
SK (1) SK19412000A3 (is)
TR (1) TR200003858T2 (is)
YU (1) YU78100A (is)
ZA (1) ZA200007157B (is)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4919565B2 (ja) * 1999-08-23 2012-04-18 アボツト・ヘルスケア・プロダクツ・ベー・ブイ 新規なフェニルピペラジン
DE10219035A1 (de) * 2002-04-29 2003-11-13 Bayer Cropscience Ag Biphenylcarboxamide
US7153858B2 (en) * 2003-01-31 2006-12-26 Epix Delaware, Inc. Arylpiperazinyl compounds
MX2009004898A (es) 2006-11-09 2009-05-19 Hoffmann La Roche Derivados de indol y de benzofurano-2-carboxamida.
WO2010051561A1 (en) * 2008-11-03 2010-05-06 Chemocentryx, Inc. Compounds for the treatment of osteoporosis and cancers
CA2794153C (en) 2010-03-25 2018-01-02 Glaxosmithkline Llc Substituted indoline derivatives as perk inhibitors
CN106243088B (zh) 2015-06-03 2019-01-04 广东东阳光药业有限公司 取代的哌嗪化合物及其使用方法和用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9305641D0 (en) 1993-03-18 1993-05-05 Merck Sharp & Dohme Therapeutic agents
DE4414113A1 (de) 1994-04-22 1995-10-26 Merck Patent Gmbh 3-Indolylpiperidine
IL114026A (en) * 1994-06-08 1999-06-20 Lundbeck & Co As H 4-aryl-1-(indanmethyl dihydrobenzofuranmethyl or dihydrobenzo thiophenemethyl) piperidines tetrahydropyridines or piperazines and pharmaceutical compositions containing them
ZA9711376B (en) 1996-12-20 1998-07-21 Lundbeck & Co As H Indole or dihydroindole derivatives

Also Published As

Publication number Publication date
AR018899A1 (es) 2001-12-12
IL139962A0 (en) 2002-02-10
ZA200007157B (en) 2001-11-22
EA200100056A1 (ru) 2001-06-25
EA004248B1 (ru) 2004-02-26
HK1044339A1 (zh) 2002-10-18
YU78100A (sh) 2003-04-30
SK19412000A3 (sk) 2001-07-10
TR200003858T2 (tr) 2001-06-21
ID27976A (id) 2001-05-03
US6391882B1 (en) 2002-05-21
CZ20004780A3 (cs) 2001-08-15
BR9911843A (pt) 2001-03-20
US20020128272A1 (en) 2002-09-12
KR20010071513A (ko) 2001-07-28
PL344978A1 (en) 2001-11-19
CN1336925A (zh) 2002-02-20

Similar Documents

Publication Publication Date Title
IS5875A (is) Ásetnar fenýlafleiður, framleiðsla þeirra og notkun
DE69933287D1 (de) 12,13-modifizierte epothilon-derivate
DK1454907T3 (da) Quninazolin og pyridopyrmidin-derivativer
IS6385A (is) Ný notkun og nýjar N-asabísýkló-amíð afleiður
DE69907964D1 (de) 1,2-annelierte chinolinderivate
NO20012567D0 (no) Azepinoindolderivater, fremstilling og anvendelse derav
ATE340176T1 (de) Substituierte 6,5-heterobicyclische-derivate
NO20006460L (no) 4, 5, 6 og 7-Indol og indolinderivater, deres fremstilling og anvendelse
DK1000048T3 (da) Substituerede 1,2,3,4-tetrahydronapthalenderivater
NO20011157L (no) Benzenderivater og farmasöytisk anvendelse derav
ATE231847T1 (de) Substituierte 1,2,3,4- tetrahydronaphthalinderivate
IS5942A (is) 3,3-bíarýlpíperidín og 2,2-bíarýlmorfólín afleiður
NO20004277D0 (no) Indolderivater og farmasøytiske sammensetninger omfattende det samme
NO986174D0 (no) Triazinderivater og anvendelse derav
NO20003825L (no) 1,3,4 - oxadiazolonderivater
DK1025100T3 (da) 3-substituerede tetrahydropyridopyrimidinonderivater, fremstilling og anvendelsen heraf
IS5731A (is) 4, 5, 6 og 7-indól og indólín afleiður, framleiðsla þeirra og notkun
PT963985E (pt) Derivados de di- ou triaza-espiro(4,5)decano
IS2247B (is) Bensófúran afleiður, framleiðsla þeirra og notkun
ATE240941T1 (de) 1,25-dihydroxy-16,22,23-trisdehydro- cholecalciferol-derivate
IS5334A (is) Indól og 2,3-díhýdróindól afleiður, framleiðsla þeirra og notkun
DK1175397T3 (da) 3,3-substituerede indolinderivater
DK1007523T3 (da) Indol- og 2,3-dihydroindolderivater, deres fremstilling og anvendelse
DK1127052T3 (da) Substituerede 2-phenylbenzimidazoler, fremstilling og anvendelse heraf